BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31498151)

  • 21. A patent and literature review of CDK12 inhibitors.
    Tang R; Liu J; Li S; Zhang J; Yu C; Liu H; Chen F; Lv L; Zhang Q; Yuan K; Shao H
    Expert Opin Ther Pat; 2022 Oct; 32(10):1055-1065. PubMed ID: 36120913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cdk12 Is A Gene-Selective RNA Polymerase II Kinase That Regulates a Subset of the Transcriptome, Including Nrf2 Target Genes.
    Li X; Chatterjee N; Spirohn K; Boutros M; Bohmann D
    Sci Rep; 2016 Feb; 6():21455. PubMed ID: 26911346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SIRT1 promotes metastasis of human osteosarcoma cells.
    Zhang N; Xie T; Xian M; Wang YJ; Li HY; Ying MD; Ye ZM
    Oncotarget; 2016 Nov; 7(48):79654-79669. PubMed ID: 27793039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas.
    Honoki K; Tsutsumi M; Miyauchi Y; Mii Y; Tsujiuchi T; Morishita T; Miura S; Aoki M; Kobayashi E; Tamai S
    Cancer Res; 1993 Oct; 53(20):5038-42. PubMed ID: 8402697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo.
    Morrow JJ; Mendoza A; Koyen A; Lizardo MM; Ren L; Waybright TJ; Hansen RJ; Gustafson DL; Zhou M; Fan TM; Scacheri PC; Khanna C
    Clin Cancer Res; 2016 Dec; 22(24):6129-6141. PubMed ID: 27342399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDK12: a potential therapeutic target in cancer.
    Emadi F; Teo T; Rahaman MH; Wang S
    Drug Discov Today; 2020 Dec; 25(12):2257-2267. PubMed ID: 33038524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors.
    Zhang T; Kwiatkowski N; Olson CM; Dixon-Clarke SE; Abraham BJ; Greifenberg AK; Ficarro SB; Elkins JM; Liang Y; Hannett NM; Manz T; Hao M; Bartkowiak B; Greenleaf AL; Marto JA; Geyer M; Bullock AN; Young RA; Gray NS
    Nat Chem Biol; 2016 Oct; 12(10):876-84. PubMed ID: 27571479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cdk12 is essential for embryonic development and the maintenance of genomic stability.
    Juan HC; Lin Y; Chen HR; Fann MJ
    Cell Death Differ; 2016 Jun; 23(6):1038-48. PubMed ID: 26658019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
    Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
    J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
    Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
    Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role and therapeutic potential of CDK12 in human cancers.
    Chilà R; Guffanti F; Damia G
    Cancer Treat Rev; 2016 Nov; 50():83-88. PubMed ID: 27662623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer.
    Dieter SM; Siegl C; Codó PL; Huerta M; Ostermann-Parucha AL; Schulz E; Zowada MK; Martin S; Laaber K; Nowrouzi A; Blatter M; Kreth S; Westermann F; Benner A; Uhrig U; Putzker K; Lewis J; Haegebarth A; Mumberg D; Holton SJ; Weiske J; Toepper LM; Scheib U; Siemeister G; Ball CR; Kuster B; Stoehr G; Hahne H; Johannes S; Lange M; Herbst F; Glimm H
    Cell Rep; 2021 Jul; 36(3):109394. PubMed ID: 34289372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDK12 Activity-Dependent Phosphorylation Events in Human Cells.
    Bartkowiak B; Yan CM; Soderblom EJ; Greenleaf AL
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31652541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative Mass Spectrometry to Interrogate Proteomic Heterogeneity in Metastatic Lung Adenocarcinoma and Validate a Novel Somatic Mutation CDK12-G879V.
    Zhang X; Nguyen KD; Rudnick PA; Roper N; Kawaler E; Maity TK; Awasthi S; Gao S; Biswas R; Venugopalan A; Cultraro CM; Fenyö D; Guha U
    Mol Cell Proteomics; 2019 Apr; 18(4):622-641. PubMed ID: 30617155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.
    Wu YM; Cieślik M; Lonigro RJ; Vats P; Reimers MA; Cao X; Ning Y; Wang L; Kunju LP; de Sarkar N; Heath EI; Chou J; Feng FY; Nelson PS; de Bono JS; Zou W; Montgomery B; Alva A; ; Robinson DR; Chinnaiyan AM
    Cell; 2018 Jun; 173(7):1770-1782.e14. PubMed ID: 29906450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of MFH290: A Potent and Highly Selective Covalent Inhibitor for Cyclin-Dependent Kinase 12/13.
    Liu Y; Hao M; Leggett AL; Gao Y; Ficarro SB; Che J; He Z; Olson CM; Marto JA; Kwiatkowski NP; Zhang T; Gray NS
    J Med Chem; 2020 Jul; 63(13):6708-6726. PubMed ID: 32502343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability.
    Choi SH; Martinez TF; Kim S; Donaldson C; Shokhirev MN; Saghatelian A; Jones KA
    Genes Dev; 2019 Apr; 33(7-8):418-435. PubMed ID: 30819820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
    Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
    Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of ezrin in osteosarcoma metastasis.
    Ren L; Khanna C
    Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development, validation, and evaluation of a deep learning model to screen cyclin-dependent kinase 12 inhibitors in cancers.
    Wen T; Wang J; Lu R; Tan S; Li P; Yao X; Liu H; Yi Z; Li L; Liu S; Gao P; Qian H; Xie G; Ma F
    Eur J Med Chem; 2023 Mar; 250():115199. PubMed ID: 36827953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.